Panagiotis Sarantis

49PUBLICATIONS
59CO-AUTHORS
GlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 13, 2026
Semaglutide and Liraglutide Modulate Oxidative Stress and Wound Repair in Normal Human Skin Cells Exposed to an In Vitro Diabetic-like Environment.

|Jul 13, 2026
Enhanced anti-tumor effects of Imatinib and immune checkpoint inhibitors on gastrointestinal stromal tumor cells (GISTs): insights from monoculture and 3D co-culture models.

|Jun 26, 2026
Microsatellite Phenotype as a Guide for Immunotherapy in Colorectal Cancer: Current Status and Future Perspectives.

|May 27, 2026
Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications.

|Mar 27, 2026
Advances in Extracellular Matrix Metalloproteinases: Implications for Renal Cell Carcinoma Pathophysiology, Diagnostics, and Therapeutics.

Evangelia Krikou, Ioanna A Anastasiou, Panagiotis Sarantis

|Feb 24, 2026
The Role of HER2 and RANK in Breast Cancer and New Therapeutic Approaches With Denosumab, Anti-HER2 Antibodies and Immunotherapy.

Panagiotis Sarantis, Aristofania Simatou, Ioanna A Anastasiou

Pageof 9

Frequent Collaborators

33 joint publications

Michalis V Karamouzis

15 joint publications

Nikolaos Garmpis

13 joint publications

Christos Damaskos

9 joint publications

Eleni-Myrto Trifylli